MDM2 Polymorphism, Survival, and Histology in Early-Stage Non–Small-Cell Lung Cancer

Volume: 25, Issue: 16, Pages: 2243 - 2247
Published: Jun 1, 2007
Abstract
MDM2 is a negative regulator of p53. The MDM2 309T/G polymorphism has been associated with differential MDM2 expression levels and inhibition of the p53 pathway. We hypothesized that the MDM2 G/G genotype may be associated with worse survival outcomes in lung cancer, especially in squamous cell cancers where p53 abnormalities are more common.We evaluated the relationship between MDM2 polymorphism status and overall survival (OS) among patients...
Paper Details
Title
MDM2 Polymorphism, Survival, and Histology in Early-Stage Non–Small-Cell Lung Cancer
Published Date
Jun 1, 2007
Volume
25
Issue
16
Pages
2243 - 2247
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.